Background: Heart transplantation (HTx) is a life-saving therapy for infants, children and adults with end-stage heart failure or complex, inoperable congenital cardiac defects. This team performed its first case of orthotopic HTx in July 1988 and first paediatric case (recipient's age under 18 years) in March 1996. The aim of this study was to review retrospectively 15 paediatric patients who underwent orthotopic HTx. The mid-term survival results in paediatrics and adults were compared.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2007 Published by Elsevier Inc.